Revenue: The sum of all revenue fields included for a company's operating activities.
Coherus Oncology, Inc. (CHRS) had Revenue of $12.31M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$12.31M |
$-38.33M |
|
$3.81M |
|
$8.50M |
|
$48.46M |
|
$-36.15M |
|
$-0.78M |
|
$-36.94M |
|
$-36.94M |
|
$-36.94M |
|
$-36.94M |
|
$-38.33M |
|
$-36.94M |
|
$-36.15M |
|
$-35.27M |
|
136.40M |
|
136.40M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$206.03M |
|
$1.09M |
|
$59.99M |
|
$266.02M |
|
$132.33M |
|
$37.15M |
|
$55.07M |
|
$187.40M |
|
$78.62M |
|
$33.01M |
|
$78.62M |
|
154.22M |
|
| Cash Flow Statement Financials | |
$-57.89M |
|
$30.66M |
|
$53.59M |
|
$89.12M |
|
$115.48M |
|
$26.36M |
|
$2.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.56 |
|
-- |
|
-- |
|
0.32 |
|
0.47 |
|
69.02% |
|
-293.67% |
|
-293.67% |
|
-- |
|
-300.04% |
|
-311.35% |
|
$-57.89M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.79 |
|
0.55 |
|
164.57 |
|
-46.98% |
|
-111.89% |
|
-13.88% |
|
-31.90% |
|
$0.51 |
|
$-0.42 |
|
$-0.42 |
|